IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q2 2020 Holdings

Filed 2020-08-17 | 11 holdings | $40.8M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2020-08-20) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$40.5M151,42099.2%
United Therapeutics Corp(UTHR)COM91307C102$57.2K472,5480.1%
Alexion Pharmaceuticals Inc(ALXN)COM015351109$55.4K493,1700.1%
Regeneron Pharmaceuticals(REGN)COM75886F107$49.7K79,6910.1%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$38.3K763,1030.1%
Taro Pharmaceutical IndusCOMM8737E108$34.7K521,5070.1%
Mckesson Corp(MCK)COM58155Q103$33.2K216,1420.1%
Alkermes PLC(ALKS)ACOMG01767105$30.4K1,564,6650.1%
RTI Surgical HDS IncCOM74975N105$18.6K5,851,5720.0%
Invacare CorpCOM461203101$5.6K876,4210.0%
Anaptysbio Inc(ANAB)COM032724106$4.1K184,8460.0%